Preliminary in-vitro studies of BMY-28232, the active metabolite of the BMY-28271 cephalosporin ester.
Jones
R M
RM
Clinical Microbiology Institute, Tualatin, Oregon 97062.
D001419:Bacteria / Q000187:drug effects*; D002511:Cephalosporins / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests
D002511:Cephalosporins; C058032:BMY 28232; C060354:BMY 28271